These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 23819731)

  • 1. Factors influencing health related quality of life in cancer patients with bone metastases.
    Wong E; Chow E; Zhang L; Bedard G; Lam K; Fairchild A; Vassiliou V; Alm El-Din MA; Jesus-Garcia R; Kumar A; Forges F; Tseng LM; Hou MF; Chie WC; Bottomley A
    J Palliat Med; 2013 Aug; 16(8):915-21. PubMed ID: 23819731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. International field testing of the reliability and validity of the EORTC QLQ-BM22 module to assess health-related quality of life in patients with bone metastases.
    Chow E; Nguyen J; Zhang L; Tseng LM; Hou MF; Fairchild A; Vassiliou V; Jesus-Garcia R; Alm El-Din MA; Kumar A; Forges F; Chie WC; Bottomley A;
    Cancer; 2012 Mar; 118(5):1457-65. PubMed ID: 21837676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality of life in responders after palliative radiation therapy for painful bone metastases using EORTC QLQ-C30 and EORTC QLQ-BM22: results of a Brazilian cohort.
    Mendez LC; Raman S; Wan BA; da Silva JLP; Moraes FY; Lima KMLB; Silva MF; Diz MDPE; Chow E; Marta GN
    Ann Palliat Med; 2017 Aug; 6(Suppl 1):S65-S70. PubMed ID: 28595442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective study validating the EORTC QLQ-BM22 bone metastases module in patients with painful bone metastases undergoing palliative radiotherapy.
    Raman S; Ding K; Chow E; Meyer RM; Nabid A; Chabot P; Coulombe G; Ahmed S; Kuk J; Dar AR; Mahmud A; Fairchild A; Wilson CF; Wu JS; Dennis K; DeAngelis C; Wong RK; Zhu L; Brundage M
    Radiother Oncol; 2016 May; 119(2):208-12. PubMed ID: 27157890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the EORTC QLQ-BM22 and the BOMET-QOL quality of life questionnaires in patients with bone metastases.
    Bedard G; Zeng L; Poon M; Lam H; Lauzon N; Chow E
    Asia Pac J Clin Oncol; 2014 Jun; 10(2):118-23. PubMed ID: 23551978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants of quality of life in advanced cancer patients with bone metastases undergoing palliative radiation treatment.
    Lam K; Chow E; Zhang L; Wong E; Bedard G; Fairchild A; Vassiliou V; Alm El-Din M; Jesus-Garcia R; Kumar A; Forges F; Tseng LM; Hou MF; Chie WC; Bottomley A
    Support Care Cancer; 2013 Nov; 21(11):3021-30. PubMed ID: 23775156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the EORTC QLQ-BM22 and the FACT-BP for assessment of quality of life in cancer patients with bone metastases.
    Popovic M; Nguyen J; Chen E; Di Giovanni J; Zeng L; Chow E
    Expert Rev Pharmacoecon Outcomes Res; 2012 Apr; 12(2):213-9. PubMed ID: 22458622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality of life after palliative radiation therapy for patients with painful bone metastases: results of an international study validating the EORTC QLQ-BM22.
    Zeng L; Chow E; Bedard G; Zhang L; Fairchild A; Vassiliou V; Alm El-Din MA; Jesus-Garcia R; Kumar A; Forges F; Tseng LM; Hou MF; Chie WC; Bottomley A
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):e337-42. PubMed ID: 22763028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A brief instrument to measure health-related quality-of-life in patients with bone metastasis: validation of the German version of Bone Metastases Quality-of-Life-10 (BOMET-QoL-10).
    Marschner N; Wilke J; Reschke D; Kaiser F; Schmoor C; Grugel R; Boller E
    J Med Econ; 2018 Sep; 21(9):920-929. PubMed ID: 29874105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire for patients with bone metastases: the EORTC QLQ-BM22.
    Chow E; Hird A; Velikova G; Johnson C; Dewolf L; Bezjak A; Wu J; Shafiq J; Sezer O; Kardamakis D; van der Linden Y; Ma B; Castro M; Arnalot PF; Ahmedzai S; Clemons M; Hoskin P; Yee A; Brundage M; Bottomley A;
    Eur J Cancer; 2009 May; 45(7):1146-1152. PubMed ID: 19097882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding the EORTC QLQ-BM22, the module for patients with bone metastases.
    Chow E; Bottomley A
    Expert Rev Pharmacoecon Outcomes Res; 2009 Oct; 9(5):461-5. PubMed ID: 19817529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of the Chinese version of EORTC QLQ-BM22 in patients with bone metastases.
    Zhang L; Su YJ; Chen JY; Liao ZC; Luo ZQ; Xie SM; Zhang J; Lin YS; Guo H; Sun WL; Pekbay B; Miller AR; Luo L; Rui YH; Li MH; Wang CL
    Support Care Cancer; 2016 Mar; 24(3):1019-24. PubMed ID: 26245496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EORTC QLQ-BM22 quality of life evaluation and pain outcome in patients with bone metastases from breast cancer treated with zoledronic acid.
    Yeh DC; Chen DR; Chao TY; Chen SC; Wang HC; Rau KM; Feng YH; Chang YC; Lee KD; Ou-Yang F; Kuo WH; Chang KJ; Lin YC; Tseng LM; Hou MF
    In Vivo; 2014; 28(5):1001-4. PubMed ID: 25189922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive factors for overall quality of life in patients with advanced cancer.
    Cramarossa G; Chow E; Zhang L; Bedard G; Zeng L; Sahgal A; Vassiliou V; Satoh T; Foro P; Ma BB; Chie WC; Chen E; Lam H; Bottomley A
    Support Care Cancer; 2013 Jun; 21(6):1709-16. PubMed ID: 23338229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of health-related quality of life and its main influencing factors in a Polish population of patients with bone metastases.
    Püsküllüoğlu M; Zygulska AL; Tomaszewska IM; Ochenduszko S; Konopka K; Tomaszewski KA
    Curr Probl Cancer; 2016; 40(5-6):183-197. PubMed ID: 27855962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patients' and health care professionals' evaluation of health-related quality of life issues in bone metastases.
    Harris K; Chow E; Zhang L; Velikova G; Bezjak A; Wu J; Barton M; Sezer O; Eek R; Shafiq J; Yee A; Clemons M; Brundage M; Hoskin P; van der Linden Y; Johnson CD; Bottomley A;
    Eur J Cancer; 2009 Sep; 45(14):2510-8. PubMed ID: 19635661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of health-related quality of life with the European Organization for Research and Treatment of Cancer QLQ-C15-PAL after palliative radiotherapy of bone metastases.
    Caissie A; Zeng L; Nguyen J; Zhang L; Jon F; Dennis K; Holden L; Culleton S; Koo K; Tsao M; Barnes E; Danjoux C; Sahgal A; Simmons C; Chow E
    Clin Oncol (R Coll Radiol); 2012 Mar; 24(2):125-33. PubMed ID: 21917431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvements in health-related quality of life by comprehensive cancer pain therapy: a pilot study with breast cancer outpatients under palliative chemotherapy.
    Puetzler J; Feldmann RE; Brascher AK; Gerhardt A; Benrath J
    Oncol Res Treat; 2014; 37(9):456-62. PubMed ID: 25231685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EORTC QLQ-BM22 and QLQ-C30 quality of life scores in patients with painful bone metastases of prostate cancer treated with strontium-89 radionuclide therapy.
    Kurosaka S; Satoh T; Chow E; Asano Y; Tabata K; Kimura M; Tsumura H; Matsumoto K; Ishiyama H; Inoue Y; Hayakawa K; Baba S
    Ann Nucl Med; 2012 Jul; 26(6):485-91. PubMed ID: 22477263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An international prospective study establishing minimal clinically important differences in the EORTC QLQ-BM22 and QLQ-C30 in cancer patients with bone metastases.
    Zeng L; Chow E; Zhang L; Tseng LM; Hou MF; Fairchild A; Vassiliou V; Jesus-Garcia R; Alm El-Din MA; Kumar A; Forges F; Chie WC; Bedard G; Bottomley A
    Support Care Cancer; 2012 Dec; 20(12):3307-13. PubMed ID: 22562607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.